Compared to the initial resected tumor specimen, the recurrent tumor possessed a loss of heterozygosity of the 1p, 10q, 17q and 19q chromosomes, as well as a new C228T TERT promoter mutation, while the status of wild-type IDH1/IDH2 was unchanged. The gene discussed is IDH2; the disease is neoplasm.